CA1320993C - Oxygen sensing pacemaker - Google Patents

Oxygen sensing pacemaker

Info

Publication number
CA1320993C
CA1320993C CA000568556A CA568556A CA1320993C CA 1320993 C CA1320993 C CA 1320993C CA 000568556 A CA000568556 A CA 000568556A CA 568556 A CA568556 A CA 568556A CA 1320993 C CA1320993 C CA 1320993C
Authority
CA
Canada
Prior art keywords
sensor
red
pacemaker
llne
infrared
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CA000568556A
Other languages
French (fr)
Inventor
Alan A. Moore
Dennis A. Brumwell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medtronic Inc
Original Assignee
Medtronic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medtronic Inc filed Critical Medtronic Inc
Application granted granted Critical
Publication of CA1320993C publication Critical patent/CA1320993C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00Measuring for diagnostic purposes; Identification of persons
    • A61B5/145Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue
    • A61B5/1455Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters
    • A61B5/1459Measuring characteristics of blood in vivo, e.g. gas concentration, pH value; Measuring characteristics of body fluids or tissues, e.g. interstitial fluid, cerebral tissue using optical sensors, e.g. spectral photometrical oximeters invasive, e.g. introduced into the body by a catheter
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/18Applying electric currents by contact electrodes
    • A61N1/32Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/362Heart stimulators
    • A61N1/365Heart stimulators controlled by a physiological parameter, e.g. heart potential
    • A61N1/36514Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by a physiological quantity other than heart potential, e.g. blood pressure
    • A61N1/36557Heart stimulators controlled by a physiological parameter, e.g. heart potential controlled by a physiological quantity other than heart potential, e.g. blood pressure controlled by chemical substances in blood

Abstract

OXYGEN SENSING PACEMAKER

ABSTRACT
A demand pacemaker which regulates its pacing rate based upon sensed oxygen saturation percentage. The pacemaker employs a two wavelength reflectance oximeter as a sensor. The sensor in-cludes an oscillator which sequentially activates red and infrared diodes. The duty cycle of the oscillator is regulated by the relative amounts of red and infrared light reflected by the blood.
The construction of the sensor allows the sensor to operate with only two conductors, optimizing it for incorporation in a stan-dard, bipolar pacing lead.

Description

~ 2 ~ 9 ~ 3 667~2-296 CROSS REFERENCE TO COMMONLY
ASSIGNED COPENDING APPLICATION

Reference is made to Canadian Patent Application Serial No. 544,546 by Baudino at al for an "Oxygen Sensing Pacemaker" filed August 14, 1987.

BACKGROUND OF THE INVENTION

The present invention relates to cardiac pacing generally and in particular to a cardiac pacemaker which reg-ulates pacing rate based upon sensed percentage of oxygen sat-uration of the blood.
The relationship between oxygen saturation of theblood and pulse rate in a healthy heart is well known. This relationship has given rise to numerous proposals for pacemakers which regulate pacing rate in response to sensed blood oxygen level. These pacemakers attempt to restore the natural relat-ionship between blood oxygen level and pulse rate in order to provide a pacemaker which paces the heart at a rate appropriate to the physiological demands of the patient's body.
An early proposal for such a pacemaker is set forth in United States Patent No. 4,202,339, issued to Wirt~feld et al.
This pacemaker takes the form of an asynchronous pacemaker which does not sense the heart's underlying electrical activity.
United States Patent No. 4,467,807, issued to sornzin discloses ,~

, :.i ' ' . ~ . ' , ! . .
' '. : ' , ' .' '' ' ~ ' ' ~ . "
~ , ~. i ~" . , a pacemaker in which the oxygen sensor's function is integrated with a sense amplifier for sensing intrinsic heart activity.
This approach is believed superior to that of Wirtzf~ld in that it avoids competing with underlying heart activity and allows the heart to beat at its own, underlying rhythm if that under-lying rhythm is appropriate.

, . ' .:
: .

~ 3 ~ 3 66742-296 SUMMARY OF THE INVENTION
The present lnvention provldes a reflned version of an oxygen senslng pacemaker ln which the oxygen sensor ls mounted on the paclng lead. The o~ygen sensor requlres only two conductors for operatlon, yet includes a two wavelength reflectance oxlmeter for lncreased accuracy. ~xperlence in the Eleld of cardiac paclng has shown that one of the more vulnerable portlons of the pacing system ls the pacing lead, whlch ls exposed to mechanlcal stres-ses. Therefore, lt ls felt that the simpler the structure of the paclng lead ls, the more rellable and durable lt ls likely to be.
In additlon, reduclng the number of conductors to two allows for easier lnstallatlon of the pacemaker and lead and allows the use of standard bipolar pacemaker and lead connector conflguratlons.
For these reasons, an oxygen sensor requlring only two conductors ls belleved deslrable.
The sensor and clrcultry are also conflgured to mlnlmlæe the current draln lmposed by the sensing reglme, whlle retalnlng the hlgh degree of accuracy and llnearlty provlded by a two wave-length reflectance oximeter. The sensor lncludes an oscillator which se~uentially activates red and lnfrared diodes. The activa-tlon times of the infrared and red diodes are determlned by the amounts of lnfrared and red llght reflected by the blood. The sensor draws substantl~lly more current when the red diode ls activated than when the infrared diodes are actlvated. This allows the pacemaker to measure the duratlons of the red and infrared diode actlvation perlods. Thls approach provldes a slgnal to the pacemaker whlch has hlgh resolution, lncreased nolse lmmunity, and ls less affected by long term fluld inflltratlon lnto the paclng lead. The lntermlttent operatlon provldes a deslrably low current drain.

~, .

- : .: ,. :

. -. ' ~32~9~3 6~742~296 Thus, in accordance with a broad aspect of the invention, there is provided a cardiac pacemaker of the type comprising pulse generatiny means for generating cardiac pacing pulses, timing means coupled to said pulse generator means for causing said pulse generator means to generate said pacing pulses at controlled intervals, and a cardiac pacing electrode coupled to said pulse generator for applying said pacing pulses to the heart, wherein said pacemaker further comprises sensor means for sensing the percentage of oxygen saturation of the blood, said sensor comprising:
red light source means for generating red light;
infrared light source means for generating infrared light;
oscillator means for sequentially activating said infrared light source means for an infrared activation period and for activating said red light source means for a red act-ivation period;
means for allowing said red and infrared light generated by said red and infrared light sources to exit said sensor and impinge upon the blood and to allow said red and infrared light reflected by said blood to reenter said sensor;
light sensing means for sensing said red and in-frared light reentering said sensor body and for regulating said red activation period and said infrared activation period .

~ , , 9 ~ 3 -2b 66742-296 dependent upon the amount of said red and infrared light reflected by the blood; and means for applying a power signal to said sensor;
and wherein said sensor means modulates said power signal applied to said sensor means in accordance with said red activation period and sa.id infrared activation period;
and wherein said pacemaker further includes monitor means for monitoring said modulated power signal applied to said sensor and for determining the relative durations of sald red and infrared periods and a timing adjustment means coupled to said monitor means for adjusting the time interval of said pacing pulses generated by said pacemaker in accordance with the relative durations of said red and infrared periods.

- . . .
: - :

: . : : , . .......................... .
~, 9 ~ 3 3 66742-~96 BRIEF DESCRIPTION OF THE DRAWINGS
Fig. 1 is a block diagram lllustrating the functlonal relatlonshlp of the ma~or elements of the pacemaker.
Flg. 2 ls a tlmlng dlagram lllustraklng the basic timlng of the pacemaker.
Flg. 3 is a graph lllustratlng the correlatlon between the paclng rate provlded by the pacemaker and the percentage of oxygen saturatlon.
Flg. 4 ls a sectlonal drawlng of the assembled oxygen sensor.
Fig. 5 ls a plan view of the top of the hybrld clrcult withln the sensor.
Flg. 6 is a plan vlew of the bottom of the hybrld clr-cult withln the sensor.
Fig. 7 ls a schematlc of the hybrld clrcult wlthin the sensor.
Fig. 8 is a timing dlagram lllustratlng the operatlon of the sensor and associated clrcultry.
F'lg. 9 1s a tlmlng dlagram illustratlng the operatlon of clrcultry whlch decodes the slgnals provlded by the sensor to pro-vlde a signal lndlcatlve of oxygen saturatlon.
Flg. 10 ls a schematlc of the pacemaker.

DETAILED DESCRIPTION OF THE DRAWINGS
Fig. 1 is a block diagram of the primary components of the pacemaker~ Basic operatlon of the pacemaker 15 described in con~unction with the tlmlng dlagram in Flg. 2.
The pacemaker ls based upon a VDD pacemaker of the type known to the art. Such a pacemaker typically lncludes a ventrl-cular pacing electrode, an atrlal amplifler and a ventrlcular amplifier, whlch sense electrlcal actlvlty ln the atrlum and v0ntrlcle of the heart, respectlvely. In the present embodlment, the atrlal ampllfier is dispensed with. However, all tlmlng clrcultry assoclated wlth the atrlal ampllfler ls retained. In ~", .

4 667~2-~96 the present embodlment, the VDD paciny clrcultry 10 is taken from the Enertrax~ pacemaker, manufactured and sold by the asslgnee of thls appllcation. However, other VDD or DDD pacemakers would provide a sultable startlng polnt, provlded they have at least the lnputs and outputs dlscussed helow. A more detalled descrlptlon of such pacemakers can be found ln U.S Patent No. 3,6~8,707 lssued to Greatbatch and U.S Patent No. 4,059,116 lssued to Adams.
The baslc operatlon of a VDD pacemaker is well known to those skilled ln the art. l'ypically, ln response to a sensed atrlal contractlon, the clrcuitry lnltlates timing of an A-V
lnterval. If no ventrlcular contractlon is sensed during the A-V
lnterval, a ventrlcular pacing pulse ls generated. After a sensed ventrlcular contractlon or a ventrlcular paclng pulse, if no underlylng atrlal or ventrlcular actlvity occurs wlthin a pre-determlned V-V lnterval, a ventrlcular paclng pulse is generated.
In the present invention, the atrial amplifier ls dlspensed with, and the sensor and assoclated clrcultry provlde a slgnal whlch the pacing clrcuitry treats as lf lt were a sensed atrlal contractlon.
By varylng the tlmlng of thls slmulated atrlal contractlon, the underlylng pacing rate of the pacemaker ls controlled.
The paclng c.Lrcultry ls coupled to the heart by means of a paclng lead 12 whlch lncludes a tlp electrode 14 and the sensor 16. Paclng occurs between the tlp electrode 14 and the can 18 of the pacemaker. Senslng oE ventricular activlty also occurs be-tween the tlp electrode 14 and the can 18 of the pacemaker. The lead 12 has two conductors 20 and 22, coupled to the paclng clr-cultry 10 and to the sensor control/decode clrcuitry 24, respect-lvely. Sensor control decode clrcuitry 24 provldes a slgnal on line 26 indlcatlve of the sensed oxygen saturatlon percentage.
The operatlon of the pacemaker can best be understood in con~unctlon wlth the timlng dlagram ln Flg. 2. The ~CG trace lllustrates the electrocardiogram of a patlent ln whlch a pace-maker accordlng to the present lnventlon has been implanted. The first QRS complex 50 :Ls a natural ventrlcular contractlon sensed . .

' ~ ~ h ~ ~ ~3 6~7~2-296 by the paclng circuitry lO. The sensed contractlon causes genera-tlon of a pulse 52 on RTRIG line 372. Sensing of the ventrlcular contraction also lnltlates an atrlal blanklng perlod whlch pre-vents the pacer from respondlng to electrlcal signals ln the atrlum. Durlng the atrlal blanklng perlod, a low loglc slgnal 54 is generated on ABLNK llne 378. The atrlal blanklng signal ex-tends until 120 ms following the sensed ventrlcular contractlon.
The varlable timer 28 (Flg. l) lncludes an RC tlmlng clrcult controlled by ABLNK llne 378 and by the slgnal lndicatlve of o~ygen saturatlon, provlded by the sensor control decode clr-cultry 24 on llne 26. Variable timer 28 begins tlmlng a varlable delay interval on expiration of the atrlal blanklng perlod at 56.
Upon time out of the variable delay lnterval at 58, timer 28 generates a slmulated atrlal sense slgnal 60 on ASEMSE llne 374.
The slmulated atrlal sense slgnal 60 causes the VDD
clrcultry 10 (Flg. l) to initiate the tlmlng of the A-V interval at 62. In addltion, the slmulated atrlal sense slgnal 78 causes the pacing clrcuitry 10 to inltiate th~ atrial blanking period, drivlng ABLNK llne 378 low at 64. At the explratlon of the A-V
interval at 66, a ventrlcular paclng pulse 67 is generated, caus-ing a posltlve slgnal 68 on RECHARGE llne 358. At the explratlon of the atrlal blar,klng lnterval at 70, tlming of the variable delay is reinitlated at 72. Thus, the interval between a sensed contractlon 50 and the next subsequent ventrlcular pacing pulse ls determlned by the sum of the A-V lnterval plus the varlable delay lnterYal determlned by varlable tlmer 28 plus 120 ms. The duratlon of the varlable delay lnterval ls determlned by -the slg-^
nal on line 26 from the sensor control/decode clrcuitry 24.
The escape lnterval followlng a ventrlcular paced beat ls determined ln a simllar fashion. Followlng the paclng pulse 67, the atrlal blanklng perlod remalns ln effect for a perlod of 120 ms. Upon e~plratlon of the atrlal blanklng perlod at 70, varlable tlmer 28 reini.tiates timlng of the varlable delay lnterval at 72. Tlme out of the variable delay interval at 74 1 ~0~3 ~ 667~2-29 trlggers the generatlon of slmulated atrlal sense slgnal 76 on ASENSE line 374. Th1s in turn inltiates tlmlng of the A-V lnter-val at 78, and lnltlate~ the atrlal blanking perlod at 80, driving ABLNK llne 378 low. At the e~piratlon of the A-V lnterval at 82, a ventricular paclng pulse 84 ls generated followed by a corres-pondlng posltlve slgnal 86 on R~CHARGE line 358.
Sensed ventricular contractlon 94 follows pacing pulse 84 by an lnterval less than the sum of 120 ms plus the A-V dela~
plus the varlable delay. Thls termlnates tlmlng o~ the A-V inter-val at 96. The atrlal blanklng perlod lnitiated at 98 by time out of the variable delay at 99 will termlnate at 100, 120 ms follow-lng sensed ventrlcular contraction 94. At that tlme, tlming of the varlable delay ls relnitlated at 102. A posltlve going signal on RTRIG llne 372 correspondlng to sensed beat 94 ls lllustrated at 104.
Pacing clrcultry 10 also lncludes a V-V tlmer. As dls-cussed above, thls tlmer sets a mlnlmum pacing rate. Thls timer is lnltlated concurrent wi.th elther sensed ventrlcular contractlons or ventrlcular paclng pulses. In the examples of Flg. 2, the V-V
timer is inltiated at 88, 90 and 92. Because the total of 120 ms plus the A-V delay plus the variable delay was less than the underlylng V-V lnterval, the V-V timer does not time out in Flg.
2. However, ln the event that the sum of 120 ms plus the varlable delay plus the A-V delay were greater than the V-V interval, pac-lng would occur on the explration of the V-V interval.
In summary, the pacemaker operates slmilarly to the pacemaker disclosed in the Bornæln patent referred to above, in that the escape lnterval following elther a sensed ventricular contraction or a paced ventricular contractlon ls determined by the sensed oxygen saturatlon percentage. Like the pacemaker descrlbed ln the Bornzln patent, senslny of natural ventricular contractlons prlor to the explratlon of the escape lnterval re-lnltlates timing of the escape interval.
The signals on RECHARGE llne 358 and RTRIG line 372 .
.. , 7 ~32~3 667~-296 are provided to the sensor control/decode clrcultry 24 where they are counted. After every fourth count, the sensor 16 ls activa-ted, and a new value of oxygen saturation ls decod~d by clrcuitry 24. This slgnal indlcative of the percentage of saturation ls provided to variable tlmer 28 on llne 26, and the variable delay interval ls correspondlngly changed.
Fig. 3 illustrates the various relatlonships between oxygen saturation and pulse rate available ln the pacemaker. The pacemaker provldes ~wo sets of curves relating oxygen saturation and pulse rate, which are referred to herea:Eter as family A and famlly B. As dlscussed above, the paclng rate is the sum of the A-V lnterval, the 120 ms atrial blanklng perlod followlng ventrl-cular pace or sense, and the varlable delay lnterval determlned by the varlable timer 28. In the particular VDD pacing circuitry utlllzed, that of the Enertrax~ pacer, there are ten avallable A-V
intervals ranging from 25 ms to 250 ms ln 25 ms increments. These control settlngs determine the curves wlthln farnily A and famlly B. For example, the curves lllustrated as A10 and ~10 employ an A-V lnterval of 25 ms, whlle the curves lllustrated as Al and ~1 employ an A-V interval of 250 ms.
The sensor/control decode loglc 24, Flg. 1, provides an output slgnal on llne 26 which is proportlonal to the sensed oxygen saturation. The specific relationship between sensed oxygen saturatlon and the outpuk signal on llne 26 ls ad~ustable between two settlngs whlch deflne the A and B famllles of curves illustrated in Flg. 3. At any partlcular sensed oxygen saturation percentage, the varlable delay lnterval in the B family is about one-half of the correspondlng variable delay ln the A famlly.
This provldes lncreased flexlbllity to optlrnize the pacemaker's operat ion for the partlcular patlent ln whlch it ls implanted.
Withln ea~h famlly of curves, any oi- the 10 A-V lntervals may be selected to produce a total of 20 posslble response curves. The speclflcs of the operatlon of sensor control/decode clrcultry 24 and variable timer clrcuitry 28 are dlscussed in more detail below , ~2~3 in con~unctlon wlth the dlscusslon of Flg. lO.
All curves lllustrated employ an underlying, V-V lnter-val of 1500 ms, correspondlng to 40 beats per minute. Thls lnter-val ls also programmable and determlnes the lowest available pac-lng rate. As discussed above, unless the sum of the A-V delay, the varlable d~lay and the 120 rns post ventrlcular atrlal blanklng interval ls less than the V-V lnterval, paclng wlll occur on ex-plratlon of the V-V lnterval.
Flg. 4 ls a sectlonal drawlng of the assembled sensor ready for lncorporatlon ln a cardlac paclng lead. The sensor lncludes a machlned sensor body 200 which may be fabrlcated of tltanium. The sensor body 200 serves both as a structural element and as a conductlve element. The dlstal end 202 of sensor body 200 ls provided wlth a bore 204, ln which a colled conductor coupled to the tlp electrode 14 (Fig. 1) of the paclng lead 12 (Flg. 1) may be mounted. The proxlmal end 206 of sensor body 200 ls preferably coupled to one of the two elongated conductors 20 and 22 (Fig. 1) ln the paclng lead 12. The sensor body 200 thus serves as part of the conductor coupllng the pacemaker to the tlp electrode. A wlre 208 enters the proxlmal end of the sensor body 200 vl~ bore 210. Bore 210 ls sealed by means of feed through 212, whlch may be fabrlcated of sapphlre and is provided wlth a metal sheath 213 whlch is welded to æensor body 200.
Sensor body 200 serves to mount the hybrld clrcult 214, whlch contalns the active clrcult elements of the sensor and ls provlded wlth a central bore 201 to allow access to the bottom of hybrld circuit 214. The circultry of hybrid clrcult 214 ls coup-led to the sensor body at lts dlstal end by means of strap 216 and ls coupled to wlre 208 at lts proxlmal end by means of wlre 218.
Surroundlng sensor body 200 ls a transparent sapphlre tube 220 which allows the lnfrared and red llght generated by the oximeter clrcultry on hybrid 214 to e~it and to reenter the sensor. Sap-phire tube 220 ls coupled to sensor body 200 by means of weldlny collars 222 and 224. Weldlng collars 222 and 224 are brazed to ,, ~
. - ,.; , . ~. :
:

. ~ , . ~ .:

~32~3 sapphire tube 220 and welded to sensor body 200. This construc-tion provides a long term, hermetically sealed sensor capsule.
Hybrld circuit 214 includeæ three L~D's, and one photo diode. The three LED's are surrounded by a semicylindrlcal shleld 232 which extends from the surface of hybrid 214 to the inner sur-face of sapphire tube 220. The photo diode ls mounted to the surface of hybrld 214 distal to cylindrlcal shleld 232. This construction minimizes direct propagation of light ~rom the LED's to the photo diode, and thus ensures that almost all light lmping-ing on the photo diode has been reflected off of the patlent'sblood.
When the sensor is incorporated into a pacing lead, it is expected that a coaxlal configuration will be used employing two coiled conductors. The outer conductor will be welded or otherwise attached to the proxlmal end 206 of sensor body 200 and the lnner conductor wlll be welded or otherwlse attached to the proximal end of wire 208. In order to encourage long term operation of the device, the .
, .
., . - - .
.
.

~, ''-. .: :

~ ~20~3 exterior of the sensor capsule may be covered by a transparent, polyurethane sheath, which may be continuous with the outer insulation of the pacing lead and also insulates sensor body 200. This structure is described in 5 more detail in commonly assigned, co-pending application by Baudino et al cited above.

Fig. 5 shows a top, plan view of hybrid 214. In this view, it can be seen that the hybrid contains two infrared 10 LED's 226 and 228 and one red LED 230. Diodes 226, 228 and 230 are mounted proximal to shield 232. Photo diode 234 is located distal to shield 232. In addition, the hybrid 214 contains an oscillator 236. Oscillator 235 alternately energizes the red diodes 226 and 228 and the 15 red diode 230. ~he reflected light impin~ing upon photo diode 234 determines the relative time periods of energization of the infrared diodes 226 and 228 and the red diode 230. Durlng the time when red diode 230 is energized, there is a current flow through the sensor 20 circuitry of approximately 6 ma. While the IR diodes 226 and 228 are energized, there is a current flow through the sensor circuitry of only approximately 2 ma. Due to the intermittent operation of the sensor, the average current drain is only about 10 microamps. The difference in 25 current drain when the red and IR diodes are activated allows the sensor control/decode circuitry within the pacemaXer to determine the relative time periods during which the diodes are energized, and thus the ratio of reflected red and infrared light. This mechanisrn will be 30 discussed in more detail in conjunction with Fig. 10, below. Areas 23%, 240 and 242 are metallization areas on the upper portion of the hybrid substrate. Plated through hole 244 couples area 240 to an additional conductive area on the back of the hybrid, as does a second plated throu~h 35 hole located under oscillator 236, coupled to conductive area 242. Wire 218 (Fiq. 4) is coupled to area 238 Strap 216 (Fig. 4! is coupled to area 242.

1~2~3 11 667~2-29 Flg. 6 lllustrates the bottom surface of hybrld 214.
Conductive areas 246 and 248 are coupled to conductive areas 240 and 242 on the top o~ hybrld 214 by means o~ plated through holes 244 and 25Q, respectlvely. Reslstor 252 is coupled to conductlve areas 246 and 248. Reslstor 252 ls located over bore 201 of sen-sor body 200 (Flg. 4) when assembled. Thls allows laser trimmlng of reslstor 252 through the sapphlre tube 220. Preferably, re-slstor 252 is trlmmed so that oscillator 236 provldes a 50 percent duty cycle for actlvatlng the red diode 230 and the lnfrared diodes 226 and 22B in the presence of blood having an ~0 percent oxygen saturatlon.
Fig. 7 ls a schematic dlagram of the sensor clrcultry.
In this view, the interrelation of the various circult ~omponents ls more clearly visible. The connection of sensor body 200, wire 208 and tlp electrode 14 ls shown ln this drawlng. All elements of the drawlng correspond to identlcally labeled elements ln Flgs 4 and 5. When a power slgnal is provided across wire 208 and sensor body 200, the tlmlng functlon of oscillator 23Ç ls lnltla-ted. Oscillator 236 upon lnitlal turn on actlvates red diode 230.
The tlming periods of the osclllator are determined by the para-sltic capacltance of photo dlode 234, the flxed reslstance of reslstor 252, and the varlable reslstance of photo dlode 234. The amount of llght reflected on photo dlode 234 varles its' effectlve reslstance and thus determlnes the red dlode actlvatlon perlod.
At the explratlon of the red dlode actlvatlon perlod, osclllator 236 actlvates dlodes 226 and 228. The lnfrared llght reflected upon photo dlode 234 thereafter determlnes the length of the IR
dlode actlvatlon period. At the expiration of the I~ dlode actl-vatlon perlod, the red dlode ls agaln actlvated. Thls oscillatlon contlnues until the power slgnal is removed from wire 208 and sensor body 200. There ls a four-fold change ln the ratlo of lnfrared to red dlode actlvatlon intervals between restlng and heavy exercise. The modulatlon of the power slgnal to sensor 16 thus allows oxyyen saturatlon percentage to be determined with a high degree of resolutlon.

~,. . . .

't~ ~ '' ' ;
": .' . .
~ ' , ' :L 3 ~ 3 Flgs. 8 and 9 are timlng dlagrams whlch lllustrate the operation of the sensor and associated clrcultry. These tlming diagrams are discussed ln con~unctlon with the schematlcs oE the clrcuitry in Fig. 10, and should be referred to ln con~unction with Flg. 10 ln order to understand the operatlon of the pacer more fully.
Figs. 10A, B, C and D lllustrate the clrcuitry assocl-ated with the sensor and its lnterconnectlon to a prior art VDD
pacemaker circultry. In partlcular, the prlor art VDD pacemaker circuitry lncludes llnear and dlgital clrcultry of the Bnertrax~
pacemaker, previously marketed by Medtronlc, Inc., wlth the excep-tlon of the atrlal sense ampllEler, whlch ls omitted. While thls clrcultry ls shown as exemplary, the sensor and associated clr~
cultry are belleved to be easlly adapted to any modern program-mable VDD or DDD pacemaker clrcultry whlch wlll provlde the requlred lnputs, outputs and tlmlng perlods.
Llnear clrcultry 300 contalns the ventrlcular sense ampllfler, the ventrlcular output ampllEier, and clrcultry assocl-ated wlth telemetry into and out of the pacemaker. Linear circultry 300 is coupled to the antenna vla ANT 1 llne 308 and ANT
2 llne 310. Both the input ampllfier and the output ampllfier of llnear clrcuitry 300 are coupled to the tlp electrode 14 and to the pacemaker can 18 vla llnes 312 and 26. Zener dlodes 320 pro-vlde protectlon for the sense ampllfler ln the event of electro-cautery or cleElbrlllatlon. SENSOR llne 324 is coupled to TIP line 326 by means of back to back zener dlodes 322, also protectlng the paclng circultry ln the event of applled deflbrillation or elec-trocautery. TIP llne 326 and SENSOR line 324 ln use are coupled to conductors 20 and 22 (Fig. 1) oE the paclng lead 12 (Flg. 1).
Tlming ~or the pacemaker ls based upon a 32 KHz crystal osclllator 304 whlch ls coupled to both the llnear and to the dlgltal clr--cultry.
Dlgltal circultry 302 takes care of the timlng Eunctions oE the pacemaker, including tlmlng of the A-V lnterval, the V-V

-~ ~ , , :
-,, . , . .~ .
, ~: ;. :

~ ~ ~ 0 ~3 lnterval and the atrlal blanklng perlod discussed ln con~unction with Flgs. 1 and 2, above. Digltal clrcult 302 also tlmes out a ventrlcular refractory perlod, as ls conventional in VDD pacers.
In the Enertrax~ pacer clrcultry, thls ls a programmable para~
meter. Dlgltal clrcult 302 also tlmes out a ventrlcular blanklng period, as ls conventlonal. E~plration of the ventrlcular blanking perlod ls indicated by a slgnal on VBLNK line 352. On explration of the V-V or A-V intervals, dlgltal clrcultry 302 yenerates a slgnal on VPAC~ llne 360 and a subsequent recharge slgnal on RECHARGE llne 356. In response to a sensed ventricular contrac-tion, llnear clrcultry 300 generates a slgnal on VS~NSE llne 354 whlch ln turn trlggers yeneratlon of a slgnal on RTRIG llne 372.
PIM llne 366 carrles data recelved by the linear clrcultry 300 to dlgltal clrcultry 302 to select programmable time lntervals, lncludlng the A-V lnterval and the V-V lnterval and to select other proyrammable optlons such as atrlal ampllfler sensltlvlty.
ASENSE llne 374 ls the lnput to the digltal circui.t 302 whlch would normally recelve the output of the atrlal sense ampll-fler. ASENS~L llne 376 ls an output from dlgltal clrcuitry 302, and lndlcates the atrial sensitlvlty level selected vla program-mlng. As there ls no atrlal ampllfler, thls line is used to select between the A and B famllies of curves and to dlsable the senslng function. ABLNK llne 378 ls an output from dlgltal clr-cultry 302 and ls low durlng the atrlal blanking lnterval.
In addltion, dlgltal clrcultry 302 provldes outputs con-trolllng the operation of the telemetry functlons of the llnear clrcultry 300. These lnclude a telemetry enable signal, generated on TELEN llne 370 and a telemetry data slgnal generated on TELDATA
line 368. The TELEN

` . ~ .
`~ ' ' '` `

j .

-14- ~ ~ 2 ~ 66742-296 line 370 is high when telemetry function is enabled, which occurs only in the presence of a low signal on REEDSW line 353.
TELDATA line 368 is high when the device is telemetering out digital information from the memory of digital circuitry 302.
When TELEN line 370 is high and TELDATA line 368 is low, the device is adapted for analog telemetry. Normally, the pac~maker would telemeter out the electrocardio~ram sensed by the tip electrode 14. Telemetry of this information takes the form of pulse interval modulation, based upon the current applied to VCO capacitor 332. In the present invention, the current app-lied to VCO capacitor 332 is used to telemeter out the sensed oxygen saturation.
The programming and timing functions of prior art VDD pacemakers are discussed in more detail in United States Patent Mo. 4,344.437 issued to Markowitz. It is believed that one skilled in the art would be familiar with these basic functions, which would be present in most modern VDD and DDD
pacemakers, and that the basic sensor related circuit archit-ectures set forth herein would be easily adaptable to such pacemakers.
The positive terminal of the battery is coupled to B+ line 318, which is coupled to capacitors 336, 338 and 340 along with resistor 334 to provide the VCC signal on VCC line 346. This is used as the basic power signal for the sensor control and timing circuitry. The negative terminal of the i: ` ` `
~ . .
:, . , ~ 3 2 ~
~14a- 66742-296 battery is coupled to B- line 328 and to ground. The pacemaker is preferably powered by an LiMnO2 cell, which generates a three volt output and has low internal impedance. The low impedance of the cell allows it to abruptly increase its current output when required by sensor activation. Basic timing funct-ions for the sensor circuitry are taken from the 32 KHz crystal oscillator via XTAL line 348 and from the pacemaker slow clock via SLOWCLK line 350. SLOWCLK line 350 merely provides a clock signal at 8 ms intervals. Fig. lOA also . , ; . ' ~ ' ,. , , , . ' ': :, ^,, ., ~ . . ~ , : :
: . . .-- . . . -. . :
.
. : : .~ ::

: . . . . .

6~742-296 illustrates interconnect llnes includlng the POWERON H line 342, POWERON L line 344, and RATIOCTR H line 382.
Fig. 10B includes the variable tlmer 28, illustrated in Fi~. 1, along wlth a portion of the sensor control and decodlng clrcuitry 24. For purposes of convenlence, the sensor control and decode clrcultry on Flg. 10~3 can be divlded lnto s~uare wave to DC
clrcult 492 and sensor control clrcuitry 493.
Sensor control circultry 493 uses the outputs of digital clrcuitry 302 to control sensor tlmlng and operation. Pacing and senslng events are counted by counter 476, which is lncremented by OR gate 466 which is responslve to elther a slgnal on the RECHARGE
llne 358 or on RTRIG llne 372. As such, wlth each sensed ventrl-cular contractlon or ventrlcular pacing pulse, counter 476 is lncremented by 1. When the counter reaches a count of four, 4TH
EVENT llne 394 goes hlgh. This initiates sensor operatlon. In addltlon, when the fourth event is counted, a nPgatlve set slgnal ls applled to fllp-flop 462 vla inverter 464. Thls causes a hlgh signal on the Q output of fllp-flop 462. This ln turn serves as a clear slgnal for counter 476 through reslstor 488. The clear slynal sets the output of Q3 of counter 476 low, drlvlng the slgnal on 4TH EVENT llne 394 low and removlng the negatlve set signal from fllp-flop 462. When flip-flop 462 is set, POWERON H
line 342 goes hlyh. The Q output of fllp-flop 462 correspondlngly sets POWERON L llne 344 low.
When PO~ERON H llne 342 goes high, the negative reset is removed from flip-flop 478. Flip-flop 478 keeps track of the operation of the sensor, and enables the sensor to operate for one full infrared and one full red time period. When the signal on RED L line 384 goes high, indicative of the beginning or the flrst in~rared dlode activation interval, the Q output of fllp-flop 478 goes hlgh generating a hlgh slgnal on SENSORACT H line 392. On the beglnnlng of the next lnfrared activation perlod, the signal on RED L llne 384 wlll go high again, clocklng the Q output of fllp-flop 478 through, setting SENSORACT H line 392 low. The Q

.
l ' 1~ 132~3 66742-296 output of fllp-f1Op 478 controls the logic level of SENSORACT L
llne 391.
Fig. 10B also includes circultry whlch disables the sensor ln the event that the programming of the devlce indlcates that sensor operatlon i5 not deslred. In the event that sensor operatlon ls not deslred, ASENSEL llne 376 ls set high, whlch causes FET 434 in the square wave to DC clrcuit 4g2 to generate a low signal on the lnput of OR gate 470. OR gate 470 ln turn gen-erates a negatlve reset signal to fllp-flop 462, preventing the POWERON H line 342 from going posltive to provide power to the sensor.
Counter 474 functlons to dlvlde the 3~ KHz signal on XTAL llne 348 by 16. This provldes a 2 KHz square wave slgnal on 2 KHz llne 386. When the sensor ls dlsabled, the negatlve slgnal from OR gate 470 is inverted by lnverter 472 to provlde a posltiv~
clear slgnal to counter 474, preventlng lts operation. Inverter 468 lnverts the slgnal on XTAL, llne 34~. Thls inverted slgnal appears on 32 KHz llne 388, where lt ls subsequently used by the sensor decodlng clrcuitry illustrated ln Fig. 10D.
Flg. 10C lncludes several clrcult blocks. Clrcult block 490 ls the sensor bias clrcultry which powers the sensor 16 (Fig.
1). In response to a low signal on POWERON L llne 344, translstor 488 and associated reslstors 484 and 486 couple B~ llne 318 to TIP
line 326, whlch ls coupled to sensor body 230 (Fig. 4). The high loglc slgnal on POWERON H llne 342 turns on FET 498 and provides a return path to ground (B-) for SENSOR line 324.
To understand the operatlon of thls clrcult, reference is made to the timing diagram of Flg. 8. RECHARGE line 358 goes hlgh at 626 concurrent wlth the negatlve edge of the 510w clock at 620. It remalns high untll the expiratlon of the next subsequent slow clock pulse 622. The negative golng edge 62~ of the recharge pulse clocks counter 478 (Flg. 10B). Assumlng lt ls the fourth count, counter 476 drlves 4TH EVENT line 394 hlgh at 630. As dls-cussed above, this sets the Q output of flip-flop 462 (Flg. 10B) ;

, . . -.,:

' 17 ~ ~ 2 ~ 3 ~ 3 ~6742-296 high at 632. Thls turns on transistors 488 and 498 and provldes power to the sensor clrcultry. When translstors 488 and 498 are turned on, osclllator 236 (Flg. 7) is activated, causlng current to flow through red diode 230 (Flg. 7). However, start up tran-sients make ~he current level 660 on SENSOR line 324 in~tially unstable. Thls flrst red diode activatlon perlod ls therefore not approprlate for use, and ls ignored.
When the lnltlal slgnal on SENSOR line 324 reaches approxlmately 4 ma due to red LED 230 activation, the clrcultry ln clrcult block 494 ls activated. Translstors 510 and 520, and assoclated reslstors 508, 516, 518 and 522, along wlth dlodes 512 and 514 act as a toggle fllp-flop wlth a predetermlned power-up state ln whlch translstor 510 ls off and translstor 520 ls on.
Dlodes 512 and 514 are collector clamp dlodes for translstor 510, and limlt the collector voltage swlng to 1.2 volts. Thls enhances the swltchlng tlme of translstor 510 and reduces the current drain. When the current on SENSOR llne 324 exceeds 4 ma, the flip-flop lncludlng transistors 510 and 520 ls trlggered via trlgger capacltor 504, reslstor 506 and translstor 502. Thls turns transistor 520 off, drivlng R~D H line 482 hlgh at 642 (Flg.
8).
At the explratlon of the flrst red LED actlvatlon lnter-val at 662, the signal on SENSOR llne 324 drops to 2 ma wlth the actlvatlon of the two IR dlodes 226 and 228 (Flg. 7), Thls ~gain toggles the flip-flop, turnlng translstor 520 on and 510 off.
This sets the slgnal on RED H llne 482 low at 644 (Flg. 8). The low slgnal on RED H llne 482 is lnverted vla lnverter 548 (Flg.
10~) and provlded as a high slgnal on RED L llne 384 (Flg. 10D).
Thls signal acts a~ clock to fllp-flop 478 (Flg. 10B), setting SFNSORACT H llne 392 hlgh at 650 (Flg. 8).
To follow the operation of the decoding clrcultry fur-ther, lt 18 necessary to refer to Flg. 10D. Fig. 10D should also be revlewed ln coniunctlon wlth the tlmlny dlagrams of Flgs. 8 and 9.

... .

.
.
: , :~2~3 1~ 66742-296 Fiy. 10D illustrates the counter system used for decod-ing the ratio of the IR dlode actlvation period to the red dlode activatlon perlod. Counters 552 and 564 count the red and lnfra-red dlode activation perlods, respectively. The high slgnal 630 (Fig. 8) on 4TH EVENT line 394 resets counters 552 and 564.
SENSORACT L line 391 goes low at 650 (Flg. 8). This allows the 32 KHz signal on llne 388 to pass through negatlve lnput NAND gate 546 on llne 612 at 654 (Flg. 83. Slmultaneously, SENSORACT H llne 392 goes hlgh, dlsabllng counters 562, 554 and 556. Because RED H
llne 482 is then low at 644 (Flg. 8), negatlve lnput NAND gate 556 ls enabled to pass through the 32 KHz slgnal on llne 614 at 656 (Fig. 8). This serves as the clock signal to drive IR counter 564. The 32 KHz slgnal ls applled to the clock lnput o~ counter 564 until the osclllakor 236 (Flg. 7) activates the red dlode.
When the dlode 230 1~ actlvated at 664, RED H llne 482 is set high at 646 (Fig~ 8). When RED H line 482 goes high, thls ln turn pre-vents the 32 KHz slgnal from passlng through negatlve lnput AND
gate 556 to llne 614, as illustrated at 657 (Flg. 8). Negative input AND gate 550 1~ then enabled to pass the 32 KHz slgnal through on llne 616 at 658 (Fig. 8) to serve as a clock slgnal to counter 552. At the explratlon of the red L~D actlvatlon period at 666, R~D H line 482 goes low at 648.
When RED H llne 4~2 goes low, th0 slgnal ls passed through lnverter 548 to RED L llne 384, which in turn clocks fllp-flop 478 (Flg. 10B), drlvlng SENSORACT L line 391 high and SENSORACT H llne 392 low at 650 (Flg. 8). The Q output of fllp-flop 478 also clocks fllp-flop 462 (Flg. 10B) via NOR gate 460, to drive POW~RON H llne 342 low and POWERON L llne 344 hlgh at 633 (Flg. 8), turn:lng off translstors 488 and 498 ~Flg. 10C) and turn-ing off the sensor.
When the slgnal on S~NSORACT H line 392 goes low, this provides a negative counter enable signal to counters 554 and 556, whlch functlon as ~am ln down counters, taking inputs from red counter 552. A low slgnal on SENSORACT H line 392 also enables , "; , .
: - ~ ~ . . ...
., . . ~ i: . ~ .
-- , , 19 ~2~3 66742-296 counter 562 whlch acts as a ~am in down counter for counting down the number stored ln counter 564. Counters 554, 556 and 562 recelve clock slgnals from the 2 KHz llne 386 and resume countlng.
The contents of counters 552 and 564 wlll be ~ammed ln tlming cycles thereafter until the sensor is reactivated.
Counters 554, 556 and 562 all are clocked ~y the 2 KHz signal on line 386. Because the contents of counter 552 are ~am-med into counter~ 554 and 556 beginning with the third counter stage while the contents of counter 564 are ~ammed lnto counter 562 beginnlng with the first counter stage, tlme out of counter 556 is always later than time out o~ counter 562. When counter 562 counts down to 0, the 2 KHz clock slgnal to counter 562 is dlsabled vla lnverter 560 and negatlve input AND gate 568. This also sets the slgnal on RATIOCTR L line 396 low and the slgnal on RATIOCTR H llne 382 hlgh. Counter 562 remalns dlsa~led untll counter 556 counts down to 0. When counter 556 counts down to 0, the contents of counter 552 are again ~ammed into counters 554 and 556 and on the next subsequent 2 KHz clock cycle, the contents of 564 are ~ammed into counter 562 via negative input NAND gate 558.
Thls also sets RATIOCTR L llne 396 low and RATIOCTR H llne 382 hlgh. RATIOCTR L line 3g6 thus provldes a modulated square wave slgnal ln whlch the duty cycle is based upon the relative time outs of counters 556 and 552.
Basic tlming of the circuitry of Fig. lOD is illustrated in Fig. 9, which shows counter 556 reaching 0, driving its zero detect output low at 676. On the next subsequent negative golng transition of the 2 KHz signal on llne 386, the output of negative input NAND gate 558 goes low at 678. Thl~ causes the contents of counter 564 to be ~ammed lnto counter 562 at the next positlve golng transitlon of the 2 KHz slgnal on llne 386, at 680. On that same positive going transition, the contents of counter 552 are iammed into counter 554, causing the zero detect output of counter 556 to go high at 682. Counters 562, 554 and 556 contlnue to count until the zero detect output of counter S62 goes low at 682.

.
~' , ' ' ~' ' .

~ 3 66742-296 Thls negatlve slgnal is lnverted by inverter 560 and applled to negatlve AND gate 568 to dlsable further countlng by counter 562.
In the meantlme, counter 556 continues to count untll its zero detect output goes low at 684, initiatlng the restart of counters 554 and 556 at 686 and the restart of counter 562 at 688, as a result of the slgnal at 690 from NAND gate 558. RATIOCTR L llne 396 ls taken from the zero detect output of counter 564.
Further decodlng of the sensor value takes place in the clrcultry ln Fig. 10B, whlch should be examlned in con~unctlon wlth the timlng diagram of Fig. 8. The slgnal on RATI0CTR L line 396 ls applled to the square wave to DC clrcult 492. This cir-cuitry converts the square wave slgnal on RATIOCTR L llne 396 to a DC current, proportlonal to the duty cycle of the square wave slg-nal. The slgnal on RATIOCTR L line 396 ls applied to J-F~T 410, whlch, in con~unction wlth as oclated reslstors 406 and 412, clamp the high level voltage of the square wave slgnal from RATIOCTR L
line 396 at approxlmately 2.5 volts. Thls slgnal ls applied to the negatlve lnput of dlfferentlal ampllfler 400 vla reslstor 414.
J FET 418, ln con~unctlon wlth associated reslstors 420 and 422 provldes an o~fset reference voltage of approxlmately .5 volts DC
which ls provided to the positlve lnput of dlfferentlal ampll1er 400. Differentlal amplifler 400 ln con~unctlon wlth FET's 432, 434 and assoclated reslstors 436, 430, 408, 404 and capacltor 402 provide a controlled current sink through translstor 428.
FETs 432 and 434 are controlled by the slgnal level on ASENSEL llne 376. When the slgnal on ASENSEL llne 376 ls hlgh, FET 434 is on and sensor operatlon ls dlsabled vla OR gate 470, as dlscussed above. When the slgnal on ASENSEL llne 376 ls low, translstor 432 ls actlvated. Thls provldes greater currents through transistor 428, resulting ln a shorter range of varlable delay lntervals generated by varlable timer 28. Thls settlng of ASENSEL produces the ~ famlly of curves, descrlbed above in con-~unctlon wlth Fig. 3. If the slgnal on ASENSEL llne 376 ls merely a hlgh lmpedance state, then FET 432 ls off. This reduces current - ~ : . ,, :
' ~

:~2~9~3 flow through translstor 428 and produces the A famlly o~ curves, described above ln con~unctlon with Fig. 3.
In summary, the ~unction o~ the square wave to DC cur-rent circult 492 is to provide a current slnk proportlonal to the duty cycle of the slgnal on RATIOCTR L llne 396. The loglc state of ASENSEL line 376 allows the cholce of two relatlonships between the duty cycle on RATIOCTR L line 396 and the current slnk provi-ded through translstor 428.
The variable timer circuitry 28 includes a timing capac-ltor 438, wlth a charging rate proportional to the current throughtranslskor 428. When the voltage on capacitor 438 reaches a pre-determined threshold voltage, it is detected by the threshold detector circultry including transistors 446, 456 and associated resistors 440, 452, 454, 458, 448 and 450 and capacitor 444. When the voltage on capacitor 438 reaches the threshold voltage deter-mlned by resistors 448 and 458, voltage detector transistors 446 turn on transistor 456, driving ASENSE llne 374 low. This is the simulated atrial sense signal which is used to initiate timlng of the A-V interval by digital circuit 302 (Fig. lOA), as discussed above ln con~unction with Flgs. 1, 2 and 3. The low slgnal on ASENSE line 374 initiates the atrial blanking period, drivlng ABLNK line 378 low, turning on transistor 426 : ,.

:~32~

which discharges capacitor 438 and disables variable interval timer 28. At the expiration of the atrial blanking period, ABLNK line 378 will go high, restarting variable timer 28.
Fig. 10C includes ratio square wave telemetry circuit 496, which allows for telemetry of the measured oxygen value out of the pacemaker to an external programmer. In the Enertrax~ pacemaker~ telemetry o~ analog information is accomplished by varying the charging current to VCO
10 capacitor 332 (Pig. 1) to modulate the pulse intervals of telemetry signals provided to the antenna by linear circuitry 300. This system is general1y d~scribed in U~S.
Patent No. 4,556,063 issued to Thompson et al, and U~S.
Patent No. 4,374,382 issued to Markowit~.
Transistor 528 serves as an external current source to modulate the voltage on VCO capacitor 332. The square wave signal on RATIOCTR H line 382 is divided by resistors 524 and 526 and applied to the base of transistor 528.
20 Transistor 528 is controlled by ~ET 542, which turns on transistor 528 via inverter 536 and resistor 530 only when the signal on TELEMEN line 370 is high and when the signal on TELEMDATA line 368 is low. This indicates that the pacing circuitry is enabled for telemetry transmission and 25 that no digital telemetry is being transmitted at that time. In addition, FET 542 also activates FET 532 which prevents electrical signals in the heart from affectin~
the VCO capacitor 332. In the event that the sensor circuitry is acti.vated during telemetry, it will still 30 function normally, due to the high impedance of resistor 534, which allows TIP line 326 to go high when transistor :~ 488 is turned on. The high impedance of resistor 326 also allows generation of pacing pulses during telemetry of the ;~ sensed oxygen saturation percentageO

' ,;
.~-.'~ ';' . ' '',.
: . .: , . .

-23- ~ ~3 ' CQMPONE~NT LISTINÇ;
C~unters Type Transistors ~ype 554,556,562 HC40103 432,434,532,542 3N169 552,564 HC4040 410,418 2N4338 474,476 HC393 498 VN35 Flip-Flops 488 2N2907 . .
462,478 HC74 502,510,520 2N2484 OR-Gates 456,428 2N2484 466,470 E~C32 528,426 2N379 N~R-Gates 446 2N3811 . . .
460 HC02 Amplii~ier NEG. AND Gates 400 TLC251 ~ "
550, 556, 568 EIC02 Oscillator NEG. NAND Gates 236 ICM7242 546,558 HC32 ~iodes In~erters 512,514 1N914 536,548,560 4069 226,22~ OPC-123 468,472,464 4069 TRW
CapacLtors ~alue 234 OPC-910 402 2.2uF TRW
336 100uF 230 H-1000 338 68uF Stanley 340 . n 1 u F Re s i sto r s Val ue 444 560pF 334 5K Ohms 504 1uF 48~ 18K Ohms 332 150pF 486,508,506 10K Ohms 438 .68uF 516,522 1 OK Ohms 454,534,540 1M Ohms 538,436,450 lM Ohms 480,452 1M Ohms 5301524 15M Ohms 544,430 1 OM Ohms 526 5M Ohms 422 150K-350K Ohms 412 250K-1.5M Ohms 420,406 226K Ohms 414 3.3M Ohms .~ ,. "
' '- ~., ~, , -2~ 2~

Resistors ~ant. ~alues Cont.
404 5.SM Ohms 408,409 374K Ohms 425 3M Ohms 440 750K Ohms 442 560~ Ohms 448 600K Ohms 458 2.2M Ohms 500 10 Ohms 252 400 Ohms 518 470K Ohms The above description sets forth the invention in its present form. However, the inven t ion should not be considered as limited to the specific sensor and 15 associated circuitry disclosed herein. In the particular embodiment disclosed herein, the sensor and associated circuitry are optimized for use in conjunction with the circuitry from a particular prior art pacer. However, the invention should not be considered limited to such an 20 embodiment. In conjunction with the above description, we claim:

..: , " ...

~;''' :' ' '~, ~-, ''

Claims (6)

1. A cardiac pacemaker of the type comprising pulse generating means for generating cardiac pacing pulses, timing means coupled to said pulse generator means for causing said pulse generator means to generate said pacing pulses at controlled intervals, and a cardiac pacing electrode coupled to said pulse generator for applying said pacing pulses to the heart, wherein said pacemaker -further comprises sensor means for sensing the percentage of oxygen saturation of the blood, said sensor comprising:
red light source means for generating red light;
infrared light source means for generating infrared light;
oscillator means for sequentially activating said infrared light source means for an infrared activation period and for activating said red light source means for a red activation period;
means for allowing said red and infrared light generated by said red and infrared light sources to exit said sensor and impinge upon the blood and to allow said red and infrared light reflected by said blood to reenter said sensor;
light sensing means for sensing said red and infrared light reentering said sensor body and for regulating said red activation period and said infrared activation period dependent upon the amount of said red and infrared light reflected by the blood; and means for applying a power signal to said sensor; and wherein said sensor means modulates said power signal applied to said sensor means in accordance with said red activation period and said infrared activation period; and wherein said pacemaker further includes monitor means fr monitoring said modulated power signal applied to said sensor and for determining the relative durations of said red and infrared periods and a timing adjustment means coupled to said monitor means for adjusting the time interval of said pacing pulses generated by said pacemaker in accordance with the relative durations of said red and infrared periods.
2. A cardiac pacemaker according to claim 1 wherein said sensor means comprises means for modulating the current level of said power signal.
3. A cardiac pacemaker according to claim 1 or claim 2 wherein said means for applying a power signal to said sensor comprises a pair of mutually insulated conductors.
4. A pacemaker according to claim 1 further comprising an elongated electrical lead, said lead comprising conductor means for applying said power signal to said sensor.
5. A cardiac pacemaker according to claim 4 wherein said conductor means comprises only first and second mutually insulated conductors.
6. A cardiac pacemaker according to claim 5 wherein said elongated electrical lead further comprises a pacing electrode coupled to said first insulated conductor and wherein said first insulated conductor is coupled to said pulse generator within said cardiac pacemaker.
CA000568556A 1987-06-05 1988-06-03 Oxygen sensing pacemaker Expired - Fee Related CA1320993C (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US058,300 1987-06-05
US07/058,300 US4750495A (en) 1987-06-05 1987-06-05 Oxygen sensing pacemaker

Publications (1)

Publication Number Publication Date
CA1320993C true CA1320993C (en) 1993-08-03

Family

ID=22015950

Family Applications (1)

Application Number Title Priority Date Filing Date
CA000568556A Expired - Fee Related CA1320993C (en) 1987-06-05 1988-06-03 Oxygen sensing pacemaker

Country Status (5)

Country Link
US (1) US4750495A (en)
EP (1) EP0299613B1 (en)
AU (1) AU596933B2 (en)
CA (1) CA1320993C (en)
DE (1) DE3888413T2 (en)

Families Citing this family (157)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4903701A (en) * 1987-06-05 1990-02-27 Medtronic, Inc. Oxygen sensing pacemaker
US4895151A (en) * 1987-07-20 1990-01-23 Telectronics N.V. Apparatus and method for therapy adjustment in implantable
EP0301323B1 (en) * 1987-07-27 1993-05-12 Siemens Aktiengesellschaft Catheter with a built-in probe for implantation in the heart
US4815469A (en) * 1987-10-08 1989-03-28 Siemens-Pacesetter, Inc. Implantable blood oxygen sensor and method of use
US4940053A (en) * 1989-01-25 1990-07-10 Siemens-Pacesetter, Inc. Energy controlled rate-responsive pacemaker having automatically adjustable control parameters
EP0381799B2 (en) * 1989-02-10 2003-04-23 St. Jude Medical AB Implantable cardiac pacer with a synchrous rate of stimulation of the cardiac muscle limited to a maximal value
US4969465A (en) * 1989-05-19 1990-11-13 Ventritex, Inc. Cardiac therapy method
US4971058A (en) * 1989-07-06 1990-11-20 Ventritex, Inc. Cardiac therapy method with duration timer
US5040538A (en) * 1989-09-05 1991-08-20 Siemens-Pacesetter, Inc. Pulsed light blood oxygen content sensor system and method of using same
DE58909830D1 (en) * 1989-10-11 1998-03-12 Siemens Ag Medical device implantable in the body of a living being with means for stimulating tissue contractions
US4974589A (en) * 1989-10-17 1990-12-04 Siemens-Pacesetter, Inc. Automatically adjustable blanking period for implantable pacemaker
US5052388A (en) * 1989-12-22 1991-10-01 Medtronic, Inc. Method and apparatus for implementing activity sensing in a pulse generator
US5275171A (en) * 1990-08-06 1994-01-04 Siemens Pacesetter, Inc. Implantable lead and sensor
US5113862A (en) * 1990-09-25 1992-05-19 Siemens Pacesetter, Inc. Blood oxygen sensor having leakage compensation
US5193544A (en) * 1991-01-31 1993-03-16 Board Of Trustees Of The Leland Stanford Junior University System for conveying gases from and to a subject's trachea and for measuring physiological parameters in vivo
US5176137A (en) * 1991-03-01 1993-01-05 Medtronic, Inc. Apparatus for discrimination of stable and unstable ventricular tachycardia and for treatment thereof
US5176138A (en) * 1991-03-21 1993-01-05 Siemens Pacesetter, Inc. Implantable pacemaker having means for automatically adjusting stimulation energy as a function of sensed so2
US5267564A (en) 1991-06-14 1993-12-07 Siemens Pacesetter, Inc. Pacemaker lead for sensing a physiologic parameter of the body
US5243979A (en) * 1991-11-15 1993-09-14 Medtronic, Inc. Method and apparatus for implementing activity sensing in a pulse generator
JPH07504596A (en) * 1992-06-30 1995-05-25 メドトロニック インコーポレーテッド Electrical medical stimulators and electrical stimulation methods
AU661179B2 (en) * 1992-06-30 1995-07-13 Medtronic, Inc. Method and apparatus for treatment of angina
US5342406A (en) * 1992-10-07 1994-08-30 Medtronic, Inc. Oxygen sensor based capture detection for a pacer
US5336244A (en) * 1992-10-07 1994-08-09 Medtronic, Inc. Temperature sensor based capture detection for a pacer
US5282839A (en) * 1992-12-14 1994-02-01 Medtronic, Inc. Rate responsive cardiac pacemaker and method for providing an optimized pacing rate which varies with a patient's physiologic demand
US5312454A (en) * 1992-12-14 1994-05-17 Medtronic, Inc. Apparatus and method of automatically adjusting a sensor signal comparator threshold for an oxygen sensing pacemaker
US5354318A (en) * 1993-04-30 1994-10-11 Medtronic, Inc. Method and apparatus for monitoring brain hemodynamics
US5411532A (en) * 1993-06-04 1995-05-02 Pacesetter, Inc. Cardiac pacemaker having integrated pacing lead and oxygen sensor
US5372607A (en) * 1993-06-23 1994-12-13 Medtronic, Inc. Method and apparatus for monitoring pacemaker intervals
DE4329898A1 (en) * 1993-09-04 1995-04-06 Marcus Dr Besson Wireless medical diagnostic and monitoring device
US5411531A (en) * 1993-09-23 1995-05-02 Medtronic, Inc. Method and apparatus for control of A-V interval
US5622182A (en) * 1994-06-27 1997-04-22 Jaffe; Richard A. System for measuring core body temperature in vivo
AU3299995A (en) 1994-10-04 1996-04-18 Medtronic, Inc. Protective feedthrough
US5735884A (en) * 1994-10-04 1998-04-07 Medtronic, Inc. Filtered feedthrough assembly for implantable medical device
US5556421A (en) * 1995-02-22 1996-09-17 Intermedics, Inc. Implantable medical device with enclosed physiological parameter sensors or telemetry link
US5535752A (en) * 1995-02-27 1996-07-16 Medtronic, Inc. Implantable capacitive absolute pressure and temperature monitor system
AU4760196A (en) * 1995-02-27 1996-09-18 Medtronic, Inc. External patient reference sensor
US5564434A (en) * 1995-02-27 1996-10-15 Medtronic, Inc. Implantable capacitive absolute pressure and temperature sensor
US6073048A (en) * 1995-11-17 2000-06-06 Medtronic, Inc. Baroreflex modulation with carotid sinus nerve stimulation for the treatment of heart failure
US5746697A (en) * 1996-02-09 1998-05-05 Nellcor Puritan Bennett Incorporated Medical diagnostic apparatus with sleep mode
EP0872210B1 (en) * 1997-04-18 2006-01-04 Koninklijke Philips Electronics N.V. Intermittent measuring of arterial oxygen saturation of hemoglobin
US6144866A (en) * 1998-10-30 2000-11-07 Medtronic, Inc. Multiple sensor assembly for medical electric lead
US5902326A (en) * 1997-09-03 1999-05-11 Medtronic, Inc. Optical window for implantable medical devices
US6125290A (en) * 1998-10-30 2000-09-26 Medtronic, Inc. Tissue overgrowth detector for implantable medical device
US6248080B1 (en) 1997-09-03 2001-06-19 Medtronic, Inc. Intracranial monitoring and therapy delivery control device, system and method
US6198952B1 (en) 1998-10-30 2001-03-06 Medtronic, Inc. Multiple lens oxygen sensor for medical electrical lead
US6134459A (en) * 1998-10-30 2000-10-17 Medtronic, Inc. Light focusing apparatus for medical electrical lead oxygen sensor
US6731976B2 (en) 1997-09-03 2004-05-04 Medtronic, Inc. Device and method to measure and communicate body parameters
US6125291A (en) * 1998-10-30 2000-09-26 Medtronic, Inc. Light barrier for medical electrical lead oxygen sensor
US6024704A (en) 1998-04-30 2000-02-15 Medtronic, Inc Implantable medical device for sensing absolute blood pressure and barometric pressure
US6402689B1 (en) * 1998-09-30 2002-06-11 Sicel Technologies, Inc. Methods, systems, and associated implantable devices for dynamic monitoring of physiological and biological properties of tumors
US6163723A (en) 1998-10-22 2000-12-19 Medtronic, Inc. Circuit and method for implantable dual sensor medical electrical lead
US6052623A (en) * 1998-11-30 2000-04-18 Medtronic, Inc. Feedthrough assembly for implantable medical devices and methods for providing same
US6162180A (en) * 1998-12-28 2000-12-19 Medtronic, Inc. Non-invasive cardiac monitoring system and method with communications interface
US6171252B1 (en) 1999-04-29 2001-01-09 Medtronic, Inc. Pressure sensor with increased sensitivity for use with an implantable medical device
US6592519B1 (en) 2000-04-28 2003-07-15 Medtronic, Inc. Smart microfluidic device with universal coating
CA2429127A1 (en) * 2000-11-09 2002-05-16 Sicel Technologies, Inc. In vivo detection of biomolecule concentrations using fluorescent tags
US7011814B2 (en) 2001-04-23 2006-03-14 Sicel Technologies, Inc. Systems, methods and devices for in vivo monitoring of a localized response via a radiolabeled analyte in a subject
US6697655B2 (en) * 2001-10-05 2004-02-24 Mortara Instrument, Inc. Low power pulse oximeter
US7557353B2 (en) * 2001-11-30 2009-07-07 Sicel Technologies, Inc. Single-use external dosimeters for use in radiation therapies
US6997879B1 (en) 2002-07-09 2006-02-14 Pacesetter, Inc. Methods and devices for reduction of motion-induced noise in optical vascular plethysmography
US7738935B1 (en) 2002-07-09 2010-06-15 Pacesetter, Inc. Methods and devices for reduction of motion-induced noise in pulse oximetry
US7657482B1 (en) * 2002-07-15 2010-02-02 Paymentech, L.P. System and apparatus for transaction fraud processing
US7139613B2 (en) * 2002-09-25 2006-11-21 Medtronic, Inc. Implantable medical device communication system with pulsed power biasing
US7013178B2 (en) * 2002-09-25 2006-03-14 Medtronic, Inc. Implantable medical device communication system
US20040158294A1 (en) * 2003-02-12 2004-08-12 Medtronic, Inc. Self-powered implantable element
EP1594551A2 (en) * 2003-02-19 2005-11-16 Sicel Technologies, Inc. In vivo fluorescence sensors, systems, and related methods operating in conjunction with fluorescent analytes
US7286884B2 (en) 2004-01-16 2007-10-23 Medtronic, Inc. Implantable lead including sensor
US20050159801A1 (en) * 2004-01-16 2005-07-21 Medtronic, Inc. Novel implantable lead including sensor
US8025624B2 (en) * 2004-02-19 2011-09-27 Cardiac Pacemakers, Inc. System and method for assessing cardiac performance through cardiac vibration monitoring
US7488290B1 (en) 2004-02-19 2009-02-10 Cardiac Pacemakers, Inc. System and method for assessing cardiac performance through transcardiac impedance monitoring
US20050234519A1 (en) * 2004-04-15 2005-10-20 Ziegler Paul D Cardiac stimulation device and method for automatic lower pacing rate optimization
US7329226B1 (en) 2004-07-06 2008-02-12 Cardiac Pacemakers, Inc. System and method for assessing pulmonary performance through transthoracic impedance monitoring
US7493174B2 (en) * 2004-09-23 2009-02-17 Medtronic, Inc. Implantable medical lead
US7775966B2 (en) 2005-02-24 2010-08-17 Ethicon Endo-Surgery, Inc. Non-invasive pressure measurement in a fluid adjustable restrictive device
US7927270B2 (en) 2005-02-24 2011-04-19 Ethicon Endo-Surgery, Inc. External mechanical pressure sensor for gastric band pressure measurements
US7775215B2 (en) 2005-02-24 2010-08-17 Ethicon Endo-Surgery, Inc. System and method for determining implanted device positioning and obtaining pressure data
US7658196B2 (en) 2005-02-24 2010-02-09 Ethicon Endo-Surgery, Inc. System and method for determining implanted device orientation
US8016744B2 (en) 2005-02-24 2011-09-13 Ethicon Endo-Surgery, Inc. External pressure-based gastric band adjustment system and method
US8066629B2 (en) 2005-02-24 2011-11-29 Ethicon Endo-Surgery, Inc. Apparatus for adjustment and sensing of gastric band pressure
US7699770B2 (en) 2005-02-24 2010-04-20 Ethicon Endo-Surgery, Inc. Device for non-invasive measurement of fluid pressure in an adjustable restriction device
US8781847B2 (en) * 2005-05-03 2014-07-15 Cardiac Pacemakers, Inc. System and method for managing alert notifications in an automated patient management system
US20060253300A1 (en) * 2005-05-03 2006-11-09 Somberg Benjamin L System and method for managing patient triage in an automated patient management system
US20100063840A1 (en) * 2005-05-03 2010-03-11 Hoyme Kenneth P System and method for managing coordination of collected patient data in an automated patient management system
US9168383B2 (en) 2005-10-14 2015-10-27 Pacesetter, Inc. Leadless cardiac pacemaker with conducted communication
EP1948296B2 (en) 2005-10-14 2017-10-11 Pacesetter, Inc. Leadless cardiac pacemaker and system
JP4848732B2 (en) * 2005-10-17 2011-12-28 株式会社日立製作所 Terminal device
US7729773B2 (en) * 2005-10-19 2010-06-01 Advanced Neuromodualation Systems, Inc. Neural stimulation and optical monitoring systems and methods
US20070156085A1 (en) * 2005-12-30 2007-07-05 Schulhauser Randal C Implantable perfusion sensor
US7787947B2 (en) * 2006-03-31 2010-08-31 Medtronic, Inc. Method and apparatus for using an optical hemodynamic sensor to identify an unstable arrhythmia
US7647095B2 (en) * 2006-03-31 2010-01-12 Medtronic, Inc. Method and apparatus for verifying a determined cardiac event in a medical device based on detected variation in hemodynamic status
US8095205B2 (en) * 2006-03-31 2012-01-10 Medtronic, Inc. Method and apparatus for verifying a determined cardiac event in a medical device based on detected variation in hemodynamic status
US8152710B2 (en) 2006-04-06 2012-04-10 Ethicon Endo-Surgery, Inc. Physiological parameter analysis for an implantable restriction device and a data logger
US8870742B2 (en) 2006-04-06 2014-10-28 Ethicon Endo-Surgery, Inc. GUI for an implantable restriction device and a data logger
US7809441B2 (en) 2006-05-17 2010-10-05 Cardiac Pacemakers, Inc. Implantable medical device with chemical sensor and related methods
US7669883B2 (en) * 2007-03-29 2010-03-02 Newfrey Llc Air bag bracket/fastener
US8187163B2 (en) 2007-12-10 2012-05-29 Ethicon Endo-Surgery, Inc. Methods for implanting a gastric restriction device
US8100870B2 (en) 2007-12-14 2012-01-24 Ethicon Endo-Surgery, Inc. Adjustable height gastric restriction devices and methods
US8377079B2 (en) 2007-12-27 2013-02-19 Ethicon Endo-Surgery, Inc. Constant force mechanisms for regulating restriction devices
US8142452B2 (en) 2007-12-27 2012-03-27 Ethicon Endo-Surgery, Inc. Controlling pressure in adjustable restriction devices
US8192350B2 (en) 2008-01-28 2012-06-05 Ethicon Endo-Surgery, Inc. Methods and devices for measuring impedance in a gastric restriction system
US8591395B2 (en) 2008-01-28 2013-11-26 Ethicon Endo-Surgery, Inc. Gastric restriction device data handling devices and methods
US8337389B2 (en) 2008-01-28 2012-12-25 Ethicon Endo-Surgery, Inc. Methods and devices for diagnosing performance of a gastric restriction system
US8221439B2 (en) 2008-02-07 2012-07-17 Ethicon Endo-Surgery, Inc. Powering implantable restriction systems using kinetic motion
US7844342B2 (en) 2008-02-07 2010-11-30 Ethicon Endo-Surgery, Inc. Powering implantable restriction systems using light
US8114345B2 (en) 2008-02-08 2012-02-14 Ethicon Endo-Surgery, Inc. System and method of sterilizing an implantable medical device
US8591532B2 (en) 2008-02-12 2013-11-26 Ethicon Endo-Sugery, Inc. Automatically adjusting band system
US8057492B2 (en) 2008-02-12 2011-11-15 Ethicon Endo-Surgery, Inc. Automatically adjusting band system with MEMS pump
US8034065B2 (en) 2008-02-26 2011-10-11 Ethicon Endo-Surgery, Inc. Controlling pressure in adjustable restriction devices
US8187162B2 (en) 2008-03-06 2012-05-29 Ethicon Endo-Surgery, Inc. Reorientation port
US8233995B2 (en) 2008-03-06 2012-07-31 Ethicon Endo-Surgery, Inc. System and method of aligning an implantable antenna
US8532793B2 (en) * 2008-04-30 2013-09-10 Medtronic, Inc. Techniques for placing medical leads for electrical stimulation of nerve tissue
US9968788B2 (en) * 2008-10-29 2018-05-15 Medtronic, Inc. Timing coordination of implantable medical sensor modules
US9192769B2 (en) * 2008-10-31 2015-11-24 Medtronic, Inc. Shunt-current reduction techniques for an implantable therapy system
US8532779B2 (en) * 2008-10-31 2013-09-10 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US8560060B2 (en) 2008-10-31 2013-10-15 Medtronic, Inc. Isolation of sensing and stimulation circuitry
US8498698B2 (en) 2008-10-31 2013-07-30 Medtronic, Inc. Isolation of sensing and stimulation circuitry
US8688210B2 (en) * 2008-10-31 2014-04-01 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US8527045B2 (en) * 2008-10-31 2013-09-03 Medtronic, Inc. Therapy system including cardiac rhythm therapy and neurostimulation capabilities
US8260412B2 (en) 2008-10-31 2012-09-04 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US9775987B2 (en) 2008-10-31 2017-10-03 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US8452394B2 (en) 2008-10-31 2013-05-28 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US8774918B2 (en) * 2008-10-31 2014-07-08 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US9597505B2 (en) * 2008-10-31 2017-03-21 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US8611996B2 (en) 2008-10-31 2013-12-17 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
US8249708B2 (en) * 2008-10-31 2012-08-21 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
EP2367596A1 (en) * 2008-10-31 2011-09-28 Medtronic, Inc. Shunt-current reduction housing for an implantable therapy system
US8005539B2 (en) * 2008-10-31 2011-08-23 Medtronic, Inc. Implantable medical device crosstalk evaluation and mitigation
WO2010088687A1 (en) 2009-02-02 2010-08-05 Nanostim, Inc. Leadless cardiac pacemaker with secondary fixation capability
US8346332B2 (en) * 2009-06-10 2013-01-01 Medtronic, Inc. Absolute calibrated tissue oxygen saturation and total hemoglobin volume fraction
US8515537B2 (en) * 2009-06-10 2013-08-20 Medtronic, Inc. Tissue oxygenation monitoring in heart failure
US8634890B2 (en) * 2009-06-10 2014-01-21 Medtronic, Inc. Device and method for monitoring of absolute oxygen saturation and tissue hemoglobin concentration
WO2010144648A1 (en) * 2009-06-10 2010-12-16 Medtronic, Inc. Shock reduction using absolute calibrated tissue oxygen saturation and total hemoglobin volume fraction
US8352008B2 (en) * 2009-06-10 2013-01-08 Medtronic, Inc. Active noise cancellation in an optical sensor signal
US20110066017A1 (en) * 2009-09-11 2011-03-17 Medtronic, Inc. Method and apparatus for post-shock evaluation using tissue oxygenation measurements
US8396563B2 (en) 2010-01-29 2013-03-12 Medtronic, Inc. Clock synchronization in an implantable medical device system
US8620425B2 (en) 2010-04-29 2013-12-31 Medtronic, Inc. Nerve signal differentiation in cardiac therapy
US8639327B2 (en) 2010-04-29 2014-01-28 Medtronic, Inc. Nerve signal differentiation in cardiac therapy
US8406868B2 (en) 2010-04-29 2013-03-26 Medtronic, Inc. Therapy using perturbation and effect of physiological systems
CN103249452A (en) 2010-10-12 2013-08-14 内诺斯蒂姆股份有限公司 Temperature sensor for a leadless cardiac pacemaker
US9060692B2 (en) 2010-10-12 2015-06-23 Pacesetter, Inc. Temperature sensor for a leadless cardiac pacemaker
EP2627406A1 (en) 2010-10-13 2013-08-21 Nanostim, Inc. Leadless cardiac pacemaker with anti-unscrewing feature
CN103429296A (en) 2010-12-13 2013-12-04 内诺斯蒂姆股份有限公司 Delivery catheter systems and methods
US9126032B2 (en) 2010-12-13 2015-09-08 Pacesetter, Inc. Pacemaker retrieval systems and methods
US9242102B2 (en) 2010-12-20 2016-01-26 Pacesetter, Inc. Leadless pacemaker with radial fixation mechanism
US8718763B2 (en) 2011-01-19 2014-05-06 Medtronic, Inc. Vagal stimulation
US8725259B2 (en) 2011-01-19 2014-05-13 Medtronic, Inc. Vagal stimulation
US8781582B2 (en) 2011-01-19 2014-07-15 Medtronic, Inc. Vagal stimulation
US8781583B2 (en) 2011-01-19 2014-07-15 Medtronic, Inc. Vagal stimulation
US8706223B2 (en) 2011-01-19 2014-04-22 Medtronic, Inc. Preventative vagal stimulation
EP2773416B1 (en) 2011-11-04 2019-04-24 Pacesetter, Inc. Leadless cardiac pacemaker with integral battery and redundant welds
WO2014022661A1 (en) 2012-08-01 2014-02-06 Nanostim, Inc. Biostimulator circuit with flying cell
US10716500B2 (en) 2015-06-29 2020-07-21 Cardiac Pacemakers, Inc. Systems and methods for normalization of chemical sensor data based on fluid state changes
CN108968976B (en) 2017-05-31 2022-09-13 心脏起搏器股份公司 Implantable medical device with chemical sensor
CN109381195B (en) 2017-08-10 2023-01-10 心脏起搏器股份公司 Systems and methods including electrolyte sensor fusion
CN109419515B (en) 2017-08-23 2023-03-24 心脏起搏器股份公司 Implantable chemical sensor with staged activation
CN109864746B (en) 2017-12-01 2023-09-29 心脏起搏器股份公司 Multimode analyte sensor for medical devices
CN109864747B (en) 2017-12-05 2023-08-25 心脏起搏器股份公司 Multimode analyte sensor optoelectronic interface

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3349762A (en) * 1964-10-21 1967-10-31 Optics Technology Inc Blood flow indicator and process
US3648707A (en) * 1969-07-16 1972-03-14 Medtronic Inc Multimode cardiac paces with p-wave and r-wave sensing means
US4059116A (en) * 1974-12-09 1977-11-22 Medtronic, Inc. Synchronous pacemaker with upper rate stabilization and method of use
DE2717659C2 (en) * 1977-04-21 1985-11-14 Wirtzfeld, Alexander, Prof. Dr.med., 8195 Egling Pacemaker
US4344437A (en) * 1980-04-30 1982-08-17 Medtronic, Inc. Pacemaker triggering coupling circuit
US4556063A (en) * 1980-10-07 1985-12-03 Medtronic, Inc. Telemetry system for a medical device
US4523279A (en) * 1980-11-24 1985-06-11 Oximetrix, Inc. Apparatus for determining oxygen saturation levels in blood
US4374382A (en) * 1981-01-16 1983-02-15 Medtronic, Inc. Marker channel telemetry system for a medical device
DE3107128C2 (en) * 1981-02-26 1984-07-05 Heinze, Roland, Dipl.-Ing., 8000 München Control circuit for adapting the stimulation frequency of a cardiac pacemaker to the load on a patient
US4428378A (en) * 1981-11-19 1984-01-31 Medtronic, Inc. Rate adaptive pacer
US4467807A (en) * 1981-11-23 1984-08-28 Medtronic, Inc. Rate adaptive demand pacemaker
US4791935A (en) * 1986-08-15 1988-12-20 Medtronic, Inc. Oxygen sensing pacemaker

Also Published As

Publication number Publication date
EP0299613A3 (en) 1990-05-16
AU596933B2 (en) 1990-05-17
EP0299613B1 (en) 1994-03-16
EP0299613A2 (en) 1989-01-18
AU1666888A (en) 1988-12-08
US4750495A (en) 1988-06-14
DE3888413T2 (en) 1994-06-23
DE3888413D1 (en) 1994-04-21

Similar Documents

Publication Publication Date Title
CA1320993C (en) Oxygen sensing pacemaker
US4903701A (en) Oxygen sensing pacemaker
US5800472A (en) Recommended replacement time trigger for use within an implantable rate-responsive pacemaker
US5741308A (en) Dual-chamber implantable pacemaker and method of operating same for automatically setting the pacemaker's AV interval as a function of a natural measured conduction time
CA1319176C (en) Oxygen sensing pacemaker
EP0191404B1 (en) Activity sensor for pacemaker control
US4532931A (en) Pacemaker with adaptive sensing means for use with unipolar or bipolar leads
US4606349A (en) Implantable cardiac pacer having dual frequency programming and bipolar/unipolar lead programmability
EP0872260B1 (en) Implantable pacemaker
US5318595A (en) Pacing method and system for blood flow velocity measurement and regulation of heart stimulating signals based on blood flow velocity
US5318593A (en) Multi-mode adaptable implantable pacemaker
US4807629A (en) Oxygen sensing pacemaker
US5040534A (en) Microprocessor controlled rate-responsive pacemaker having automatic rate response threshold adjustment
US4940052A (en) Microprocessor controlled rate-responsive pacemaker having automatic rate response threshold adjustment
US4567892A (en) Implantable cardiac pacemaker
US6731979B2 (en) Pulse width cardiac pacing apparatus
US4813421A (en) Oxygen sensing pacemaker
JP2623170B2 (en) Rate-responsive pacemaker
US4467807A (en) Rate adaptive demand pacemaker
US3253595A (en) Cardiac pacer electrode system
US4782836A (en) Rate adaptive cardiac pacemaker responsive to patient activity and temperature
EP0753325B1 (en) Improved upper rate response for implantable pacemaker based on atrial lock interval pacing
US5243979A (en) Method and apparatus for implementing activity sensing in a pulse generator
CA2131035C (en) Energy efficient multiple sensor cardiac pacemaker
US5176138A (en) Implantable pacemaker having means for automatically adjusting stimulation energy as a function of sensed so2

Legal Events

Date Code Title Description
MKLA Lapsed